Company Filing History:
Years Active: 2009-2011
Title: Helmut Glantschnig: Innovator in Osteoanabolic Research
Introduction
Helmut Glantschnig is a notable inventor based in Schwenksville, PA (US), recognized for his contributions to the field of osteoanabolic research. He holds a total of 3 patents, focusing on innovative solutions for bone growth and treatment of bone disorders.
Latest Patents
One of his latest patents is titled "Antibodies specific for Dkk-1." This invention describes antibodies that inhibit the binding of Dkk-1 to LRP5, which is crucial for stimulating bone growth. These antibodies are particularly useful in compositions aimed at treating bone disorders, such as osteoporosis. Another significant patent is "Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof." This invention provides rhesus monkey dickkopf-1 (rhDkk-1) and nucleotide sequences encoding it. Isolated rhDkk-1 can be utilized to screen and identify novel osteoanabolic compounds that stimulate bone formation, offering potential treatments for osteoporosis and other disorders characterized by insufficient bone mass.
Career Highlights
Throughout his career, Helmut has worked with prominent companies, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work has significantly impacted the development of therapies aimed at enhancing bone health.
Collaborations
Helmut has collaborated with esteemed colleagues such as Shun-ichi Harada and Viera Kasparcova, contributing to advancements in his field.
Conclusion
Helmut Glantschnig's innovative work in osteoanabolic research and his patented inventions play a vital role in addressing bone health issues. His contributions continue to influence the development of effective treatments for bone disorders.